Best Dabigatran Ideas An Individual Can Get

Матеріал з HistoryPedia
Версія від 13:51, 13 квітня 2017, створена Cell0linda (обговореннявнесок) (Створена сторінка: A survey of available data on genotoxicity outcomes for chemicals that have undergone cancer bioassays, taking into account that assays with OECD test guideline...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

A survey of available data on genotoxicity outcomes for chemicals that have undergone cancer bioassays, taking into account that assays with OECD test guidelines are preferred because standardized protocols greatly facilitate comparisons, found that the standardized in vivo genotoxicity assay for which data was most often available was the rodent erythrocyte micronucleus assay. However, this assay only provides information about two types of genotoxic damage (structural chromosomal damage and aneuploidy) in the hematopoietic cells of the erythrocytic lineage. Establishment of an OECD guideline for the transgenic rodent mutation assays has resulted in increasing amounts of data on gene mutations using standardized protocols, but the number of cases in which mutagenicity data were available at a sufficient number of doses in the organ/tissue Selumetinib cell line target site of carcinogenesis, and in the same species and strain in both assays, was extremely limited. Likewise, we found only a very limited number of cases in which data on pre-neoplastic http://www.selleckchem.com/products/Bortezomib.html lesions were available along with comparable cancer and genotoxicity data in comparable species, strains, tissues, and exposure regimens. In those few cases in which we did identify matched carcinogenicity and genotoxicity data, there were generally not a sufficient number of doses to obtain quantitative dose�Cresponse metrics. Thus, we were unable to identify a sufficient number of data sets to assess the quantitative correlation between carcinogenic potency and mutagenesis and clastogenesis within the same target tissue, species, strain, and sex. The dearth of such information was unexpected, and constitutes a very significant need in the field of genetic toxicology and cancer risk assessment. In Appendix 1 we present a case example that illustrates the type of quantitative analyses and comparisons that we had hoped could be conducted for a range of structurally dissimilar chemicals. This example is that of the carcinogenic and genotoxic responses in the liver of F344 rats exposed to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline Dabigatran (MeIQx) under comparable study conditions. This is the agent for which we identified the most comprehensive set of genotoxicity and carcinogenicity data under comparable study conditions. In this case, as shown in Fig. 3, early genotoxic events in the pathway to carcinogenesis showed the expected trend of lower PoDs for earlier events in the pathway to disease (DNA adducts4weeks???Mutations 16weeks?